$CYDY
CytoDyn Inc.

2020 Q2 Form 10-K Financial Statement

#000155837021009730 Filed on July 30, 2021

View on sec.gov

Income Statement

Concept 2020 Q2 2019 Q2 2019
Revenue $0.00 $0.00 $0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $7.368M $4.111M $12.12M
YoY Change 79.21% 87.74% 65.06%
% of Gross Profit
Research & Development $19.95M $9.195M $42.49M
YoY Change 116.95% 3.09% 11.16%
% of Gross Profit
Depreciation & Amortization $502.3K $497.5K $1.245M
YoY Change 0.97% 452.76% 249.64%
% of Gross Profit
Operating Expenses $27.82M $13.80M $55.85M
YoY Change 101.53% 23.29% 21.63%
Operating Profit -$55.85M
YoY Change 21.63%
Interest Expense -$7.292M -$1.090M $3.313M
YoY Change 569.18% -376.78% -44.09%
% of Operating Profit
Other Income/Expense, Net $0.00 $0.00 $0.00
YoY Change -100.0% -100.0%
Pretax Income -$57.61M -$14.89M -$63.55M
YoY Change 286.81% 54.82% 26.71%
Income Tax $0.00 $0.00 -$2.827M
% Of Pretax Income
Net Earnings -$57.61M -$14.89M -$60.72M
YoY Change 286.81% 54.76% 21.08%
Net Earnings / Revenue
Basic Earnings Per Share -$0.23
Diluted Earnings Per Share -$116.5K -$47.18K -$0.23
COMMON SHARES
Basic Shares Outstanding 364.7M
Diluted Shares Outstanding

Balance Sheet

Concept 2020 Q2 2019 Q2 2019
SHORT-TERM ASSETS
Cash & Short-Term Investments $14.28M $2.613M $2.613M
YoY Change 446.59% 112.43% 112.18%
Cash & Equivalents $14.28M $2.613M
Short-Term Investments
Other Short-Term Assets $3.399M $2.666M $2.666M
YoY Change 27.49% 27.54% 27.6%
Inventory $19.15M
Prepaid Expenses $498.0K $107.2K
Receivables
Other Receivables
Total Short-Term Assets $36.83M $5.369M $5.369M
YoY Change 585.87% 61.7% 61.7%
LONG-TERM ASSETS
Property, Plant & Equipment $55.00K $29.25K $29.25K
YoY Change 88.03% 160.52% 160.46%
Goodwill
YoY Change
Intangibles $13.46M $15.48M
YoY Change -13.05% 887.49%
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $13.69M $15.50M $15.50M
YoY Change -11.72% 882.32% 882.32%
TOTAL ASSETS
Total Short-Term Assets $36.83M $5.369M $5.369M
Total Long-Term Assets $13.69M $15.50M $15.50M
Total Assets $50.51M $20.87M $20.87M
YoY Change 141.99% 326.09% 326.09%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $29.50M $16.24M $16.24M
YoY Change 81.66% 2.51% 2.51%
Accrued Expenses $8.267M $160.0K $2.047M
YoY Change 5066.82% 175.94% 129.68%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $3.586M $3.586M
YoY Change -100.0%
Long-Term Debt Due $6.744M $4.200M $4.200M
YoY Change 60.58%
Total Short-Term Liabilities $44.50M $26.93M $26.93M
YoY Change 65.27% 60.92% 60.92%
LONG-TERM LIABILITIES
Long-Term Debt $8.431M $454.6K $454.6K
YoY Change 1754.62%
Other Long-Term Liabilities $63.39K $2.407M $2.407M
YoY Change -97.37% 82.37% 81.86%
Total Long-Term Liabilities $8.494M $2.862M $2.862M
YoY Change 196.8% 116.19% 116.2%
TOTAL LIABILITIES
Total Short-Term Liabilities $44.50M $26.93M $26.93M
Total Long-Term Liabilities $8.494M $2.862M $2.862M
Total Liabilities $53.00M $29.79M $29.79M
YoY Change 77.91% 64.97% 64.97%
SHAREHOLDERS EQUITY
Retained Earnings -$375.3M -$234.4M
YoY Change 60.1% 35.39%
Common Stock $519.0K $329.6K
YoY Change 57.49% 51.95%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$2.481M -$8.913M -$8.914M
YoY Change
Total Liabilities & Shareholders Equity $50.51M $20.87M $20.87M
YoY Change 141.99% 326.09% 326.09%

Cashflow Statement

Concept 2020 Q2 2019 Q2 2019
OPERATING ACTIVITIES
Net Income -$57.61M -$14.89M -$60.72M
YoY Change 286.81% 54.76% 21.08%
Depreciation, Depletion And Amortization $502.3K $497.5K $1.245M
YoY Change 0.97% 452.76% 249.64%
Cash From Operating Activities -$29.31M -$9.512M -$50.47M
YoY Change 208.14% 36.28% 68.79%
INVESTING ACTIVITIES
Capital Expenditures -$3.220K -$42.10K $26.00K
YoY Change -92.35%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities -$3.220K -$42.10K -$45.00K
YoY Change -92.35%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 36.55M 11.43M 52.75M
YoY Change 219.84% 250.53% 79.69%
NET CHANGE
Cash From Operating Activities -29.31M -9.512M -50.47M
Cash From Investing Activities -3.220K -42.10K -45.00K
Cash From Financing Activities 36.55M 11.43M 52.75M
Net Change In Cash 7.234M 1.873M 2.236M
YoY Change 286.27% -150.35% -510.93%
FREE CASH FLOW
Cash From Operating Activities -$29.31M -$9.512M -$50.47M
Capital Expenditures -$3.220K -$42.10K $26.00K
Free Cash Flow -$29.31M -$9.470M -$50.49M
YoY Change 209.48% 35.68% 68.88%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2021Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2020Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2021 us-gaap Impairment Of Intangible Assets Finitelived
ImpairmentOfIntangibleAssetsFinitelived
0
CY2021 dei Entity Registrant Name
EntityRegistrantName
CytoDyn Inc.
CY2021 dei Entity Central Index Key
EntityCentralIndexKey
0001175680
CY2021 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--05-31
CY2021 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2021
CY2021 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2021 dei Amendment Flag
AmendmentFlag
false
CY2020 us-gaap Loss Contingency Loss In Period
LossContingencyLossInPeriod
0
CY2019Q3 us-gaap Warrants And Rights Outstanding Term
WarrantsAndRightsOutstandingTerm
P5Y
CY2020Q1 us-gaap Warrants And Rights Outstanding Term
WarrantsAndRightsOutstandingTerm
P5Y
CY2019 cydy Adjustments To Additional Paid In Capital Offering Costs Related To Debt Offering
AdjustmentsToAdditionalPaidInCapitalOfferingCostsRelatedToDebtOffering
261000
CY2019 cydy Adjustments To Additional Paid In Capital Debt Discount Related To Debt Offering
AdjustmentsToAdditionalPaidInCapitalDebtDiscountRelatedToDebtOffering
3059000
CY2019 us-gaap Adjustments To Additional Paid In Capital Convertible Debt With Conversion Feature
AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature
3535000
CY2019 cydy Adjustments To Additional Paid In Capital Inducement Interest
AdjustmentsToAdditionalPaidInCapitalInducementInterest
196000
CY2019 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
3084000
CY2021 dei Document Type
DocumentType
10-K
CY2021 dei Document Annual Report
DocumentAnnualReport
true
CY2021 dei Document Period End Date
DocumentPeriodEndDate
2021-05-31
CY2021 dei Document Transition Report
DocumentTransitionReport
false
CY2021 dei Entity File Number
EntityFileNumber
000-49908
CY2021 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
CY2019 us-gaap Inventory Write Down
InventoryWriteDown
0
CY2020 us-gaap Inventory Write Down
InventoryWriteDown
0
CY2021 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
83-1887078
CY2021 dei Entity Address Address Line1
EntityAddressAddressLine1
1111 Main Street, Suite 660
CY2021 dei Entity Address City Or Town
EntityAddressCityOrTown
Vancouver
CY2021 dei Entity Address State Or Province
EntityAddressStateOrProvince
WA
CY2021 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
98660
CY2021 dei City Area Code
CityAreaCode
360
CY2021 dei Local Phone Number
LocalPhoneNumber
980-8524
CY2021 dei No Trading Symbol Flag
NoTradingSymbolFlag
true
CY2021 dei Security12g Title
Security12gTitle
Common Stock, par value $0.001 per share
CY2021 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2021 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2021 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2021 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2021 dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
CY2021 dei Entity Small Business
EntitySmallBusiness
true
CY2021 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2021 dei Icfr Auditor Attestation Flag
IcfrAuditorAttestationFlag
true
CY2021 dei Entity Shell Company
EntityShellCompany
false
CY2020Q4 dei Entity Public Float
EntityPublicFloat
1534001633
CY2021Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
632586877
CY2021Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
33943000
CY2020Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
14282000
CY2020Q2 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
10000
CY2021Q2 us-gaap Inventory Net
InventoryNet
93479000
CY2020Q2 us-gaap Inventory Net
InventoryNet
19147000
CY2021Q2 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
616000
CY2020Q2 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
498000
CY2021Q2 cydy Prepaid Service Fees Current
PrepaidServiceFeesCurrent
1543000
CY2020Q2 cydy Prepaid Service Fees Current
PrepaidServiceFeesCurrent
2890000
CY2021Q2 us-gaap Assets Current
AssetsCurrent
129581000
CY2020Q2 us-gaap Assets Current
AssetsCurrent
36827000
CY2021Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
712000
CY2020Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
176000
CY2021Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
134000
CY2020Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
55000
CY2021Q2 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
1653000
CY2020Q2 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
13456000
CY2021Q2 us-gaap Assets
Assets
132080000
CY2020Q2 us-gaap Assets
Assets
50514000
CY2021Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
65897000
CY2020Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
29479000
CY2021Q2 cydy Accrued Compensation And Non Financing Liabilities
AccruedCompensationAndNonFinancingLiabilities
19073000
CY2020Q2 us-gaap Dividends Payable Current
DividendsPayableCurrent
981000
CY2021Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
175000
CY2020Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
115000
CY2021Q2 us-gaap Convertible Debt Current
ConvertibleDebtCurrent
62747000
CY2020Q2 us-gaap Convertible Debt Current
ConvertibleDebtCurrent
6745000
CY2020Q2 cydy Warrant Exercise Proceeds Held In Trust
WarrantExerciseProceedsHeldInTrust
10000
CY2021Q2 us-gaap Liabilities Current
LiabilitiesCurrent
152546000
CY2020Q2 cydy Accrued Compensation And Non Financing Liabilities
AccruedCompensationAndNonFinancingLiabilities
6879000
CY2021Q2 us-gaap Interest Payable Current
InterestPayableCurrent
2007000
CY2020Q2 us-gaap Interest Payable Current
InterestPayableCurrent
292000
CY2021Q2 us-gaap Dividends Payable Current
DividendsPayableCurrent
2647000
CY2021 us-gaap Impairment Of Intangible Assets Excluding Goodwill
ImpairmentOfIntangibleAssetsExcludingGoodwill
10049000
CY2021 us-gaap Costs And Expenses
CostsAndExpenses
104596000
CY2020Q2 us-gaap Liabilities Current
LiabilitiesCurrent
44501000
CY2020Q2 us-gaap Convertible Long Term Notes Payable
ConvertibleLongTermNotesPayable
8431000
CY2021Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
552000
CY2020Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
63000
CY2021Q2 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
552000
CY2020Q2 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
8494000
CY2021Q2 us-gaap Liabilities
Liabilities
153098000
CY2020Q2 us-gaap Liabilities
Liabilities
52995000
CY2020Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2021Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2020Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000
CY2021Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000
CY2020Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2021Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2020Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
800000000
CY2021Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
800000000
CY2021Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
626123000
CY2020Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
519262000
CY2021Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
625680000
CY2020Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
518976000
CY2021Q2 us-gaap Common Stock Value
CommonStockValue
626000
CY2020Q2 us-gaap Common Stock Value
CommonStockValue
519000
CY2021Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
489650000
CY2020Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
351711000
CY2021Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-511294000
CY2020Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-354711000
CY2021Q2 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
443000
CY2020Q2 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
286000
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
-21018000
CY2020Q2 us-gaap Stockholders Equity
StockholdersEquity
-2481000
CY2021Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
132080000
CY2020Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
50514000
CY2021 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
34320000
CY2020 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
19973000
CY2019 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
12117000
CY2021 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
58430000
CY2020 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
52640000
CY2019 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
42490000
CY2021 us-gaap Cost Of Goods And Services Sold Depreciation And Amortization
CostOfGoodsAndServicesSoldDepreciationAndAmortization
1797000
CY2020 us-gaap Cost Of Goods And Services Sold Depreciation And Amortization
CostOfGoodsAndServicesSoldDepreciationAndAmortization
2034000
CY2019 us-gaap Cost Of Goods And Services Sold Depreciation And Amortization
CostOfGoodsAndServicesSoldDepreciationAndAmortization
1245000
CY2018Q2 us-gaap Stockholders Equity
StockholdersEquity
-13158000
CY2019 us-gaap Stock Issued During Period Value Acquisitions
StockIssuedDuringPeriodValueAcquisitions
11558000
CY2019 cydy Asset Purchase Equity Transfer Deferred Value
AssetPurchaseEquityTransferDeferredValue
0
CY2019 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
1455000
CY2019Q2 us-gaap Sale Of Stock Price Per Share
SaleOfStockPricePerShare
0.50
CY2019Q2 us-gaap Sale Of Stock Price Per Share
SaleOfStockPricePerShare
0.50
CY2020 us-gaap Costs And Expenses
CostsAndExpenses
74647000
CY2019 us-gaap Costs And Expenses
CostsAndExpenses
55852000
CY2021 us-gaap Operating Income Loss
OperatingIncomeLoss
-104596000
CY2020 us-gaap Operating Income Loss
OperatingIncomeLoss
-74647000
CY2019 us-gaap Operating Income Loss
OperatingIncomeLoss
-55852000
CY2020 us-gaap Other Income
OtherIncome
500000
CY2021 us-gaap Investment Income Interest
InvestmentIncomeInterest
2000
CY2020 us-gaap Investment Income Interest
InvestmentIncomeInterest
5000
CY2019 us-gaap Investment Income Interest
InvestmentIncomeInterest
4000
CY2020 us-gaap Unrealized Gain Loss On Derivatives
UnrealizedGainLossOnDerivatives
-9542000
CY2019 us-gaap Unrealized Gain Loss On Derivatives
UnrealizedGainLossOnDerivatives
1666000
CY2021 us-gaap Gains Losses On Extinguishment Of Debt Before Write Off Of Deferred Debt Issuance Cost
GainsLossesOnExtinguishmentOfDebtBeforeWriteOffOfDeferredDebtIssuanceCost
-19896000
CY2020 us-gaap Gains Losses On Extinguishment Of Debt Before Write Off Of Deferred Debt Issuance Cost
GainsLossesOnExtinguishmentOfDebtBeforeWriteOffOfDeferredDebtIssuanceCost
0
CY2019 us-gaap Gains Losses On Extinguishment Of Debt Before Write Off Of Deferred Debt Issuance Cost
GainsLossesOnExtinguishmentOfDebtBeforeWriteOffOfDeferredDebtIssuanceCost
-1520000
CY2021 us-gaap Gain Loss Related To Litigation Settlement
GainLossRelatedToLitigationSettlement
-10628000
CY2020 us-gaap Gain Loss Related To Litigation Settlement
GainLossRelatedToLitigationSettlement
-22500000
CY2021 us-gaap Debt Related Commitment Fees And Debt Issuance Costs
DebtRelatedCommitmentFeesAndDebtIssuanceCosts
147000
CY2020 us-gaap Debt Related Commitment Fees And Debt Issuance Costs
DebtRelatedCommitmentFeesAndDebtIssuanceCosts
936000
CY2021 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
3591000
CY2020 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
1645000
CY2019 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
1707000
CY2021 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
65000
CY2020 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
404000
CY2019 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
459000
CY2021 us-gaap Induced Conversion Of Convertible Debt Expense
InducedConversionOfConvertibleDebtExpense
11366000
CY2020 us-gaap Induced Conversion Of Convertible Debt Expense
InducedConversionOfConvertibleDebtExpense
7904000
CY2019 us-gaap Induced Conversion Of Convertible Debt Expense
InducedConversionOfConvertibleDebtExpense
196000
CY2021 us-gaap Interest Expense Debt Excluding Amortization
InterestExpenseDebtExcludingAmortization
4387000
CY2020 us-gaap Interest Expense Debt Excluding Amortization
InterestExpenseDebtExcludingAmortization
7330000
CY2019 us-gaap Interest Expense Debt Excluding Amortization
InterestExpenseDebtExcludingAmortization
950000
CY2021 cydy Interest And Debt Expense Excluding Gain Loss On Extinguishment Of Debt
InterestAndDebtExpenseExcludingGainLossOnExtinguishmentOfDebt
19556000
CY2020 cydy Interest And Debt Expense Excluding Gain Loss On Extinguishment Of Debt
InterestAndDebtExpenseExcludingGainLossOnExtinguishmentOfDebt
18219000
CY2019 cydy Interest And Debt Expense Excluding Gain Loss On Extinguishment Of Debt
InterestAndDebtExpenseExcludingGainLossOnExtinguishmentOfDebt
3312000
CY2021 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-154674000
CY2020 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-124403000
CY2019 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-59014000
CY2021 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
CY2020 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
CY2019 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-2827000
CY2021 us-gaap Net Income Loss
NetIncomeLoss
-154674000
CY2020 us-gaap Net Income Loss
NetIncomeLoss
-124403000
CY2019 us-gaap Net Income Loss
NetIncomeLoss
-56187000
CY2021 us-gaap Income Loss From Continuing Operations Per Basic And Diluted Share
IncomeLossFromContinuingOperationsPerBasicAndDilutedShare
-0.27
CY2020 us-gaap Income Loss From Continuing Operations Per Basic And Diluted Share
IncomeLossFromContinuingOperationsPerBasicAndDilutedShare
-0.30
CY2019 us-gaap Income Loss From Continuing Operations Per Basic And Diluted Share
IncomeLossFromContinuingOperationsPerBasicAndDilutedShare
-0.21
CY2021 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
587590000
CY2020 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
421078000
CY2019 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
272041000
CY2020 cydy Adjustments To Additional Paid In Capital Relative Fair Market Value Associatedwith Warrants Exercised
AdjustmentsToAdditionalPaidInCapitalRelativeFairMarketValueAssociatedwithWarrantsExercised
11949000
CY2019 us-gaap Gains Losses On Extinguishment Of Debt Before Write Off Of Deferred Debt Issuance Cost
GainsLossesOnExtinguishmentOfDebtBeforeWriteOffOfDeferredDebtIssuanceCost
-1520000
CY2021 us-gaap Impairment Of Intangible Assets Excluding Goodwill
ImpairmentOfIntangibleAssetsExcludingGoodwill
10049000
CY2020 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
13409000
CY2020 us-gaap Unrealized Gain Loss On Derivatives
UnrealizedGainLossOnDerivatives
-9542000
CY2019 us-gaap Unrealized Gain Loss On Derivatives
UnrealizedGainLossOnDerivatives
1666000
CY2021 us-gaap Share Based Compensation
ShareBasedCompensation
10429000
CY2020 us-gaap Share Based Compensation
ShareBasedCompensation
6548000
CY2019 us-gaap Share Based Compensation
ShareBasedCompensation
3388000
CY2021 us-gaap Gains Losses On Extinguishment Of Debt Before Write Off Of Deferred Debt Issuance Cost
GainsLossesOnExtinguishmentOfDebtBeforeWriteOffOfDeferredDebtIssuanceCost
-19896000
CY2019 us-gaap Dividends Preferred Stock
DividendsPreferredStock
37000
CY2019 cydy Adjustments To Additional Paid In Capital Legal Fees In Connection With Equity Offering
AdjustmentsToAdditionalPaidInCapitalLegalFeesInConnectionWithEquityOffering
243000
CY2019 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
3388000
CY2019 us-gaap Net Income Loss
NetIncomeLoss
-56187000
CY2019Q2 us-gaap Stockholders Equity
StockholdersEquity
-8913000
CY2020 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
10822000
CY2020 cydy Adjustments To Additional Paid In Capital Convertible Debt Fees
AdjustmentsToAdditionalPaidInCapitalConvertibleDebtFees
-3899000
CY2020 cydy Stock Issued During Period Value Warrants Exercised
StockIssuedDuringPeriodValueWarrantsExercised
20500000
CY2020 cydy Adjustments To Additional Paid In Capital Stock Issued Issuance Costs Excluding Legal Fees
AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCostsExcludingLegalFees
437000
CY2020 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
8000
CY2020 us-gaap Dividends Preferred Stock
DividendsPreferredStock
945000
CY2020 cydy Adjustments To Additional Paid In Capital Legal Fees In Connection With Equity Offering
AdjustmentsToAdditionalPaidInCapitalLegalFeesInConnectionWithEquityOffering
16000
CY2020 cydy Stock Issued For Incentive Compensation And Tendered For Income Tax Value
StockIssuedForIncentiveCompensationAndTenderedForIncomeTaxValue
154000
CY2020 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
5603000
CY2020 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
6548000
CY2020 cydy Issuance Of Stock Value Legal Settlement
IssuanceOfStockValueLegalSettlement
22500000
CY2020 us-gaap Net Income Loss
NetIncomeLoss
-124403000
CY2020Q2 us-gaap Stockholders Equity
StockholdersEquity
-2481000
CY2021 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
77703000
CY2021 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
1838000
CY2021 cydy Stock Issued For Incentive Compensation And Tendered For Income Tax Value
StockIssuedForIncentiveCompensationAndTenderedForIncomeTaxValue
828000
CY2021Q2 us-gaap Sale Of Stock Price Per Share
SaleOfStockPricePerShare
1.50
CY2021 cydy Stock Issued During Period Value Warrants Exercised
StockIssuedDuringPeriodValueWarrantsExercised
19428000
CY2021 cydy Adjustments To Additional Paid In Capital Inducement Interest
AdjustmentsToAdditionalPaidInCapitalInducementInterest
11366000
CY2021 us-gaap Dividends Preferred Stock
DividendsPreferredStock
1909000
CY2021 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
8822000
CY2021 us-gaap Net Income Loss
NetIncomeLoss
-154674000
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
-21018000
CY2021 us-gaap Net Income Loss
NetIncomeLoss
-154674000
CY2020 us-gaap Net Income Loss
NetIncomeLoss
-124403000
CY2019 us-gaap Net Income Loss
NetIncomeLoss
-56187000
CY2021 us-gaap Cost Of Goods And Services Sold Depreciation And Amortization
CostOfGoodsAndServicesSoldDepreciationAndAmortization
1797000
CY2020 us-gaap Cost Of Goods And Services Sold Depreciation And Amortization
CostOfGoodsAndServicesSoldDepreciationAndAmortization
2034000
CY2019 us-gaap Cost Of Goods And Services Sold Depreciation And Amortization
CostOfGoodsAndServicesSoldDepreciationAndAmortization
1245000
CY2021 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
65000
CY2020 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
404000
CY2019 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
459000
CY2021 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
3591000
CY2020 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
1645000
CY2019 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
1707000
CY2020 cydy Adjustment To Reconcile Net Loss To Net Cash Used In Operating Activities Litigation Settlement
AdjustmentToReconcileNetLossToNetCashUsedInOperatingActivitiesLitigationSettlement
22500000
CY2021 us-gaap Induced Conversion Of Convertible Debt Expense
InducedConversionOfConvertibleDebtExpense
11366000
CY2020 us-gaap Induced Conversion Of Convertible Debt Expense
InducedConversionOfConvertibleDebtExpense
7904000
CY2019 us-gaap Induced Conversion Of Convertible Debt Expense
InducedConversionOfConvertibleDebtExpense
196000
CY2020 cydy Interest Expense Related To Accretion Of Convertible Notes Payable
InterestExpenseRelatedToAccretionOfConvertibleNotesPayable
6615000
CY2019 cydy Interest Expense Related To Accretion Of Convertible Notes Payable
InterestExpenseRelatedToAccretionOfConvertibleNotesPayable
513000
CY2021 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
53012000
CY2019 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-2827000
CY2021 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
74332000
CY2020 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
19147000
CY2020 cydy Increase Decrease In Miscellaneous Receivable
IncreaseDecreaseInMiscellaneousReceivable
-91000
CY2019 cydy Increase Decrease In Miscellaneous Receivable
IncreaseDecreaseInMiscellaneousReceivable
91000
CY2021 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-1228000
CY2020 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
1577000
CY2019 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
464000
CY2020 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
19040000
CY2019 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
1741000
CY2021 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-117573000
CY2020 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-68804000
CY2019 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-50466000
CY2019 us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
19000
CY2021 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
122000
CY2020 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
41000
CY2019 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
26000
CY2021 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-122000
CY2020 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-41000
CY2019 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-45000
CY2021 cydy Proceeds From Warrant Transactions Net
ProceedsFromWarrantTransactionsNet
17060000
CY2021 cydy Proceeds From Issuance Of Common Stock And Warrants
ProceedsFromIssuanceOfCommonStockAndWarrants
1000000
CY2020 cydy Proceeds From Issuance Of Common Stock And Warrants
ProceedsFromIssuanceOfCommonStockAndWarrants
12666000
CY2019 cydy Proceeds From Issuance Of Common Stock And Warrants
ProceedsFromIssuanceOfCommonStockAndWarrants
38269000
CY2021 us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
19428000
CY2020 us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
38422000
CY2020 us-gaap Proceeds From Issuance Of Preferred Stock And Preference Stock
ProceedsFromIssuanceOfPreferredStockAndPreferenceStock
13409000
CY2019 us-gaap Proceeds From Issuance Of Preferred Stock And Preference Stock
ProceedsFromIssuanceOfPreferredStockAndPreferenceStock
3084000
CY2021 us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
950000
CY2020 us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
2185000
CY2020 us-gaap Payments For Repurchase Of Other Equity
PaymentsForRepurchaseOfOtherEquity
8000
CY2021 cydy Payments For Warrant Tender Offer Held In Trust
PaymentsForWarrantTenderOfferHeldInTrust
10000
CY2020 cydy Payments For Warrant Tender Offer Held In Trust
PaymentsForWarrantTenderOfferHeldInTrust
844000
CY2019 cydy Payments For Warrant Tender Offer Held In Trust
PaymentsForWarrantTenderOfferHeldInTrust
-854000
CY2021 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
1839000
CY2020 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
5602000
CY2021 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
778000
CY2020 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
89000
CY2021 us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
100000000
CY2020 us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
15000000
CY2019 us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
14877000
CY2020 cydy Payment Of Debt Conversion Offering Costs
PaymentOfDebtConversionOfferingCosts
2303000
CY2019 cydy Payment Of Debt Conversion Offering Costs
PaymentOfDebtConversionOfferingCosts
4337000
CY2021 us-gaap Payments Of Dividends Preferred Stock And Preference Stock
PaymentsOfDividendsPreferredStockAndPreferenceStock
243000
CY2021 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
137346000
CY2020 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
79670000
CY2019 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
52747000
CY2021Q2 us-gaap Inventory Net
InventoryNet
93479000
CY2020Q2 us-gaap Inventory Net
InventoryNet
19147000
CY2021Q1 cydy Inventory Number Of Batches Not Saleable
InventoryNumberOfBatchesNotSaleable
1
CY2020Q2 cydy Number Of Portions Of Biologic License Application Bla Resubmitted
NumberOfPortionsOfBiologicLicenseApplicationBlaResubmitted
2
CY2021Q2 cydy Inventory With Shelf Life Less Than One Year
InventoryWithShelfLifeLessThanOneYear
2684000
CY2021Q2 cydy Inventory With Shelf Life From One To Two Years
InventoryWithShelfLifeFromOneToTwoYears
19750000
CY2021 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
19651000
CY2020 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
10825000
CY2019 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
2236000
CY2020Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
14292000
CY2019Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
3467000
CY2018Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1231000
CY2021Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
33943000
CY2020Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
14292000
CY2019Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
3467000
CY2021Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
33943000
CY2020Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
14282000
CY2019Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
2613000
CY2020Q2 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
10000
CY2019Q2 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
854000
CY2021Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
33943000
CY2020Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
14292000
CY2019Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
3467000
CY2021 us-gaap Interest Paid Net
InterestPaidNet
147000
CY2020 us-gaap Interest Paid Net
InterestPaidNet
243000
CY2021 us-gaap Debt Conversion Converted Instrument Amount1
DebtConversionConvertedInstrumentAmount1
77703000
CY2020 us-gaap Debt Conversion Converted Instrument Amount1
DebtConversionConvertedInstrumentAmount1
15092000
CY2019 us-gaap Debt Conversion Converted Instrument Amount1
DebtConversionConvertedInstrumentAmount1
1680000
CY2021 cydy Dividends On Convertible Preferred Stock Incurred But Not Yet Paid.
DividendsOnConvertiblePreferredStockIncurredButNotYetPaid.
1666000
CY2020 cydy Dividends On Convertible Preferred Stock Incurred But Not Yet Paid.
DividendsOnConvertiblePreferredStockIncurredButNotYetPaid.
944000
CY2019 cydy Dividends On Convertible Preferred Stock Incurred But Not Yet Paid.
DividendsOnConvertiblePreferredStockIncurredButNotYetPaid.
37000
CY2021 cydy Stock Issued During Period Non Cash Value Warrant Exercised
StockIssuedDuringPeriodNonCashValueWarrantExercised
11000
CY2021 cydy Non Cash Issuance Of Stock For Legal Settlement
NonCashIssuanceOfStockForLegalSettlement
4000
CY2020 cydy Noncash Derivative Liability Associated With Warrants
NoncashDerivativeLiabilityAssociatedWithWarrants
11949000
CY2020 cydy Stock Issued During Period Value Issued For Accrued Bonus Compensation
StockIssuedDuringPeriodValueIssuedForAccruedBonusCompensation
155000
CY2020 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
3000
CY2019 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
8000
CY2019 us-gaap Stock Issued During Period Value Acquisitions
StockIssuedDuringPeriodValueAcquisitions
11558000
CY2019 us-gaap Consideration Received For Beneficial Interest Obtained For Transferring Financial Asset
ConsiderationReceivedForBeneficialInterestObtainedForTransferringFinancialAsset
3535000
CY2019 cydy Noncash Debt Discount And Issuance Costs Convertible Notes
NoncashDebtDiscountAndIssuanceCostsConvertibleNotes
3059000
CY2019 cydy Non Cash Derivative Liability Associated With Convertible Note Payable
NonCashDerivativeLiabilityAssociatedWithConvertibleNotePayable
2750000
CY2019 cydy Non Cash Finance Cost Associated With Placement Agents Warrants
NonCashFinanceCostAssociatedWithPlacementAgentsWarrants
261000
CY2021 us-gaap Prior Period Reclassification Adjustment Description
PriorPeriodReclassificationAdjustmentDescription
<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Reclassifications</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt 0pt 12pt 0pt;">Certain prior year amounts shown in the accompanying Consolidated Financial Statements have been reclassified to conform to the current period presentation. These reclassifications did not have any effect on the Company’s financial position, results of operations, stockholders’ (deficit) equity, or net cash provided by financing activities as previously reported.</p>
CY2021Q2 cydy Inventory With Shelf Life From Two To Three Years
InventoryWithShelfLifeFromTwoToThreeYears
682000
CY2021Q2 cydy Inventory With Shelf Life From Three To Four Years
InventoryWithShelfLifeFromThreeToFourYears
31425000
CY2020 us-gaap Net Income Loss
NetIncomeLoss
-124400000
CY2019 us-gaap Net Income Loss
NetIncomeLoss
-56200000
CY2021Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-511300000
CY2021 us-gaap Use Of Estimates
UseOfEstimates
<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Use of Estimates</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt 0pt 12pt 0pt;">The preparation of the Consolidated Financial Statements in accordance with U.S. GAAP requires management to make estimates and judgments that affect the reported amounts of assets, liabilities, and the disclosure of contingent assets and liabilities at the date of Consolidated Financial Statements and the reported amounts of expenses during the reporting period. Estimates are assessed each period and updated to reflect current information, such as the economic considerations related to the impact that the recent coronavirus disease could have on our significant accounting estimates and assumptions. The Company’s estimates are based on historical experience and on various market and other relevant, appropriate assumptions. Actual results could differ from these estimates.</p>
CY2021Q2 us-gaap Cash Uninsured Amount
CashUninsuredAmount
33700000
CY2020Q2 us-gaap Cash Uninsured Amount
CashUninsuredAmount
14000000.0
CY2019 us-gaap Impairment Of Intangible Assets Finitelived
ImpairmentOfIntangibleAssetsFinitelived
0
CY2020 us-gaap Impairment Of Intangible Assets Finitelived
ImpairmentOfIntangibleAssetsFinitelived
0
CY2021Q2 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
28085000
CY2020Q2 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
19147000
CY2021Q2 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
65394000
CY2018Q2 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
1324000
CY2019Q2 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
2407000
CY2020Q2 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
0
CY2021 cydy Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Forfeiture Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedForfeitureRate
0
CY2019Q2 cydy Stock Options And Warrants Outstanding Numbers
StockOptionsAndWarrantsOutstandingNumbers
178592
CY2020 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21
CY2021 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21
CY2020 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
CY2021 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
CY2019 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-2800000
CY2021Q2 cydy Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Number Of Shares Outstanding
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfSharesOutstanding
12800000
CY2021Q2 cydy Inventory With Shelf Life From Four To Five Years
InventoryWithShelfLifeFromFourToFiveYears
732000
CY2021Q2 cydy Inventory With Shelf Life Greater Than Five Years
InventoryWithShelfLifeGreaterThanFiveYears
38901000
CY2021Q2 us-gaap Inventory Gross
InventoryGross
94174000
CY2021Q2 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
695000
CY2021Q2 us-gaap Inventory Net
InventoryNet
93479000
CY2021Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
65900000
CY2020Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
29500000
CY2021Q2 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
4005000
CY2020Q2 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
1723000
CY2021Q2 us-gaap Litigation Reserve Current
LitigationReserveCurrent
11008000
CY2020Q2 us-gaap Litigation Reserve Current
LitigationReserveCurrent
400000
CY2021Q2 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
4060000
CY2020Q2 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
4756000
CY2021Q2 cydy Accrued Compensation And Non Financing Liabilities
AccruedCompensationAndNonFinancingLiabilities
19073000
CY2020Q2 cydy Accrued Compensation And Non Financing Liabilities
AccruedCompensationAndNonFinancingLiabilities
6879000
CY2021 cydy Fundamental Change Of Control Transaction Percentage Ownership Acquired
FundamentalChangeOfControlTransactionPercentageOwnershipAcquired
0.50
CY2021 cydy Share Based Compensation Number Of Active Plans
ShareBasedCompensationNumberOfActivePlans
1
CY2021 cydy Share Based Compensation Number Of Inactive Plans
ShareBasedCompensationNumberOfInactivePlans
1
CY2021 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
2600000
CY2021 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
1800000
CY2021 cydy Stock Issued During Period Value Warrants Exercised Cash
StockIssuedDuringPeriodValueWarrantsExercisedCash
19400000
CY2021 cydy Stock Issued During Period Non Cash Shares Warrant Exercised
StockIssuedDuringPeriodNonCashSharesWarrantExercised
10600000
CY2021 cydy Warrants Exercised Noncash Number Of Warrants
WarrantsExercisedNoncashNumberOfWarrants
11700000
CY2021Q2 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
4793000
CY2020Q2 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
5190000
CY2021Q2 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
1653000
CY2020Q2 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
13456000
CY2021 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
1800000
CY2020 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
2000000.0
CY2019 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
1200000
CY2020Q2 cydy Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Number Of Shares Outstanding
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfSharesOutstanding
12900000
CY2021Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares
5800000
CY2020Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares
2700000
CY2021 cydy Stock Issued During Period Shares Warrants Exercised
StockIssuedDuringPeriodSharesWarrantsExercised
27300000
CY2019Q2 cydy Stock Options And Warrants Outstanding Weighted Average Exercise Price
StockOptionsAndWarrantsOutstandingWeightedAverageExercisePrice
0.71
CY2019 cydy Stock Options And Warrants Outstanding Weighted Average Remaining Contractual Life Term
StockOptionsAndWarrantsOutstandingWeightedAverageRemainingContractualLifeTerm
P3Y7M28D
CY2019Q2 cydy Stock Options And Warrants Outstanding Aggregate Intrinsic Value
StockOptionsAndWarrantsOutstandingAggregateIntrinsicValue
896
CY2020 cydy Stock Options And Warrants Grants In Period
StockOptionsAndWarrantsGrantsInPeriod
57720
CY2020 cydy Stock Options And Warrants Grants In Period Weighted Average Exercise Price
StockOptionsAndWarrantsGrantsInPeriodWeightedAverageExercisePrice
0.47
CY2020 cydy Stock Options And Warrants Exercised In Period
StockOptionsAndWarrantsExercisedInPeriod
101853
CY2020 cydy Stock Options And Warrants Exercised In Period Weighted Average Exercise Price
StockOptionsAndWarrantsExercisedInPeriodWeightedAverageExercisePrice
0.56
CY2020 cydy Stock Options And Warrants Forfeitures And Expirations In Period
StockOptionsAndWarrantsForfeituresAndExpirationsInPeriod
3099
CY2020 cydy Stock Options And Warrants Forfeitures And Expirations In Period Weighted Average Exercise Price
StockOptionsAndWarrantsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
0.74
CY2020Q2 cydy Stock Options And Warrants Outstanding Numbers
StockOptionsAndWarrantsOutstandingNumbers
131360
CY2020Q2 cydy Stock Options And Warrants Outstanding Weighted Average Exercise Price
StockOptionsAndWarrantsOutstandingWeightedAverageExercisePrice
0.65
CY2020 cydy Stock Options And Warrants Outstanding Weighted Average Remaining Contractual Life Term
StockOptionsAndWarrantsOutstandingWeightedAverageRemainingContractualLifeTerm
P5Y9M14D
CY2020Q2 cydy Stock Options And Warrants Outstanding Aggregate Intrinsic Value
StockOptionsAndWarrantsOutstandingAggregateIntrinsicValue
302961
CY2021 cydy Stock Options And Warrants Grants In Period
StockOptionsAndWarrantsGrantsInPeriod
7036
CY2021 cydy Stock Options And Warrants Grants In Period Weighted Average Exercise Price
StockOptionsAndWarrantsGrantsInPeriodWeightedAverageExercisePrice
3.82
CY2021 cydy Stock Options And Warrants Exercised In Period
StockOptionsAndWarrantsExercisedInPeriod
75735
CY2021 cydy Stock Options And Warrants Exercised In Period Weighted Average Exercise Price
StockOptionsAndWarrantsExercisedInPeriodWeightedAverageExercisePrice
0.59
CY2021 cydy Stock Options And Warrants Forfeitures And Expirations In Period
StockOptionsAndWarrantsForfeituresAndExpirationsInPeriod
1088
CY2021 cydy Stock Options And Warrants Forfeitures And Expirations In Period Weighted Average Exercise Price
StockOptionsAndWarrantsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
1.66
CY2021Q2 cydy Stock Options And Warrants Outstanding Numbers
StockOptionsAndWarrantsOutstandingNumbers
61573
CY2021Q2 cydy Stock Options And Warrants Outstanding Weighted Average Exercise Price
StockOptionsAndWarrantsOutstandingWeightedAverageExercisePrice
0.95
CY2021 cydy Stock Options And Warrants Outstanding Weighted Average Remaining Contractual Life Term
StockOptionsAndWarrantsOutstandingWeightedAverageRemainingContractualLifeTerm
P4Y4M24D
CY2021Q2 cydy Stock Options And Warrants Outstanding Aggregate Intrinsic Value
StockOptionsAndWarrantsOutstandingAggregateIntrinsicValue
68756
CY2021Q2 cydy Stock Options And Warrants Outstanding Exercisable Number
StockOptionsAndWarrantsOutstandingExercisableNumber
55713
CY2021Q2 cydy Stock Options And Warrants Outstanding Exercisable Weighted Average Exercise Price
StockOptionsAndWarrantsOutstandingExercisableWeightedAverageExercisePrice
0.78
CY2021 cydy Stock Options And Warrants Outstanding Exercisable Weighted Average Remaining Contractual Term
StockOptionsAndWarrantsOutstandingExercisableWeightedAverageRemainingContractualTerm
P3Y11M23D
CY2021Q2 cydy Stock Options And Warrants Outstanding Exercisable Aggregate Intrinsic Value
StockOptionsAndWarrantsOutstandingExercisableAggregateIntrinsicValue
67151
CY2021Q2 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
6446000
CY2020Q2 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
18646000
CY2021Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
85000
CY2021Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
669000
CY2021Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
384000
CY2021Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
85000
CY2021Q2 cydy Finite Lived Intangible Assets Amortization Expense Thereafter
FiniteLivedIntangibleAssetsAmortizationExpenseThereafter
430000
CY2021Q2 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
1653000
CY2021Q1 cydy Acquisition Of Intangible Asset Shares Subject To Arbitration
AcquisitionOfIntangibleAssetSharesSubjectToArbitration
3100000
CY2021Q1 us-gaap Impairment Of Intangible Assets Excluding Goodwill
ImpairmentOfIntangibleAssetsExcludingGoodwill
10000000.0
CY2021Q1 cydy Impairment Of Intangible Assets Portion Charged Against Original Cost
ImpairmentOfIntangibleAssetsPortionChargedAgainstOriginalCost
12200000
CY2021Q1 cydy Impairment Of Intangible Assets Reversal Of Accumulated Amortization
ImpairmentOfIntangibleAssetsReversalOfAccumulatedAmortization
2200000
CY2021 cydy Asset Purchase Equity Transfer Deferred Number Of Shares
AssetPurchaseEquityTransferDeferredNumberOfShares
8300000
CY2021 cydy Stock Repurchase During Period Price Per Share
StockRepurchaseDuringPeriodPricePerShare
0.001
CY2021 cydy Asset Purchase Deferred Equity Transfer Number Of Installments
AssetPurchaseDeferredEquityTransferNumberOfInstallments
3
CY2021 cydy Number Of License Agreements
NumberOfLicenseAgreements
2
CY2021 cydy Annual Charges Under Agreement
AnnualChargesUnderAgreement
600000
CY2021 cydy Annual Charges Under Agreement
AnnualChargesUnderAgreement
800000
CY2020Q2 us-gaap Prepaid Royalties
PrepaidRoyalties
100000
CY2021Q2 us-gaap Prepaid Royalties
PrepaidRoyalties
100000
CY2020Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2021 us-gaap Operating Lease Cost
OperatingLeaseCost
300000
CY2020 us-gaap Operating Lease Cost
OperatingLeaseCost
200000
CY2021 us-gaap Debt Conversion Converted Instrument Shares Issued1
DebtConversionConvertedInstrumentSharesIssued1
19900000
CY2021Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
712000
CY2020Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
176000
CY2021Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
175000
CY2020Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
115000
CY2021Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
552000
CY2020Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
63000
CY2021Q2 us-gaap Operating Lease Liability
OperatingLeaseLiability
727000
CY2020Q2 us-gaap Operating Lease Liability
OperatingLeaseLiability
178000
CY2021Q2 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
202000
CY2021Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
225000
CY2021Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
175000
CY2021Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
180000
CY2021Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Five
LesseeOperatingLeaseLiabilityPaymentsDueYearFive
183000
CY2021Q2 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
965000
CY2021Q2 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
238000
CY2021Q2 us-gaap Operating Lease Liability
OperatingLeaseLiability
727000
CY2021 us-gaap Loss Contingency Loss In Period
LossContingencyLossInPeriod
10600000
CY2021Q1 cydy Number Of Independent Directors
NumberOfIndependentDirectors
3
CY2019Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2019Q3 us-gaap Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights
ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
2600000
CY2019Q3 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
0.50
CY2020Q1 us-gaap Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights
ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
300000
CY2020Q1 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
1.00
CY2020Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2019Q4 cydy Number Of Executives
NumberOfExecutives
2
CY2019Q4 cydy Number Of Executives
NumberOfExecutives
2
CY2020Q3 us-gaap Share Based Compensation
ShareBasedCompensation
1600000
CY2019 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-2800000
CY2020 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
0
CY2021 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
0
CY2021 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21
CY2021 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.210
CY2020 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.210
CY2019 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.210
CY2021 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0
CY2020 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0
CY2019 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0
CY2021 us-gaap Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Differential
EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential
0
CY2020 us-gaap Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Differential
EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential
0
CY2019 us-gaap Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Differential
EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential
0
CY2021 cydy Effective Income Tax Rate Reconciliation Loss On Debt Conversion
EffectiveIncomeTaxRateReconciliationLossOnDebtConversion
0
CY2020 cydy Effective Income Tax Rate Reconciliation Loss On Debt Conversion
EffectiveIncomeTaxRateReconciliationLossOnDebtConversion
0
CY2019 cydy Effective Income Tax Rate Reconciliation Loss On Debt Conversion
EffectiveIncomeTaxRateReconciliationLossOnDebtConversion
-0.005
CY2021 cydy Effective Income Tax Rate Reconciliation Derivative Gain Loss Percent
EffectiveIncomeTaxRateReconciliationDerivativeGainLossPercent
0
CY2020 cydy Effective Income Tax Rate Reconciliation Derivative Gain Loss Percent
EffectiveIncomeTaxRateReconciliationDerivativeGainLossPercent
-0.016
CY2019 cydy Effective Income Tax Rate Reconciliation Derivative Gain Loss Percent
EffectiveIncomeTaxRateReconciliationDerivativeGainLossPercent
0.006
CY2021 cydy Effective Income Tax Reconciliation Valuation Allowance From Asset Acquisition
EffectiveIncomeTaxReconciliationValuationAllowanceFromAssetAcquisition
0
CY2020 cydy Effective Income Tax Reconciliation Valuation Allowance From Asset Acquisition
EffectiveIncomeTaxReconciliationValuationAllowanceFromAssetAcquisition
0
CY2019 cydy Effective Income Tax Reconciliation Valuation Allowance From Asset Acquisition
EffectiveIncomeTaxReconciliationValuationAllowanceFromAssetAcquisition
0.048
CY2021 cydy Effective Income Tax Rate Reconciliation Nondeductible Expense Debt Issuance Costs Percent
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseDebtIssuanceCostsPercent
0
CY2020 cydy Effective Income Tax Rate Reconciliation Nondeductible Expense Debt Issuance Costs Percent
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseDebtIssuanceCostsPercent
-0.001
CY2019 cydy Effective Income Tax Rate Reconciliation Nondeductible Expense Debt Issuance Costs Percent
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseDebtIssuanceCostsPercent
0
CY2021 cydy Effective Income Tax Rate Reconciliation Nondeductible Expense Interest
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseInterest
-0.006
CY2020 cydy Effective Income Tax Rate Reconciliation Nondeductible Expense Interest
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseInterest
-0.012
CY2019 cydy Effective Income Tax Rate Reconciliation Nondeductible Expense Interest
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseInterest
-0.003
CY2021 cydy Effective Income Tax Rate Reconciliation Inducement Charge
EffectiveIncomeTaxRateReconciliationInducementCharge
-0.015
CY2020 cydy Effective Income Tax Rate Reconciliation Inducement Charge
EffectiveIncomeTaxRateReconciliationInducementCharge
-0.013
CY2019 cydy Effective Income Tax Rate Reconciliation Inducement Charge
EffectiveIncomeTaxRateReconciliationInducementCharge
-0.001
CY2021 us-gaap Effective Income Tax Rate Reconciliation Other Reconciling Items Percent
EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent
0
CY2020 us-gaap Effective Income Tax Rate Reconciliation Other Reconciling Items Percent
EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent
-0.003
CY2019 us-gaap Effective Income Tax Rate Reconciliation Other Reconciling Items Percent
EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent
0
CY2021 cydy Effective Income Tax Rate Reconciliation Tax Credit Carryforward
EffectiveIncomeTaxRateReconciliationTaxCreditCarryforward
-0.001
CY2020 cydy Effective Income Tax Rate Reconciliation Tax Credit Carryforward
EffectiveIncomeTaxRateReconciliationTaxCreditCarryforward
-0.001
CY2019 cydy Effective Income Tax Rate Reconciliation Tax Credit Carryforward
EffectiveIncomeTaxRateReconciliationTaxCreditCarryforward
-0.038
CY2021 cydy Effective Income Tax Rate Reconciliation Nondeductible Expense Loss On Debt Extinguishment Percent
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseLossOnDebtExtinguishmentPercent
-0.026
CY2020 cydy Effective Income Tax Rate Reconciliation Nondeductible Expense Loss On Debt Extinguishment Percent
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseLossOnDebtExtinguishmentPercent
0
CY2019 cydy Effective Income Tax Rate Reconciliation Nondeductible Expense Loss On Debt Extinguishment Percent
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseLossOnDebtExtinguishmentPercent
0
CY2021 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense Amortization
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseAmortization
-0.006
CY2020 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense Amortization
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseAmortization
-0.003
CY2019 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense Amortization
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseAmortization
0
CY2021 cydy Effective Income Tax Rate Reconciliation Non Deductible Expense Irc162 Limitation
EffectiveIncomeTaxRateReconciliationNonDeductibleExpenseIrc162Limitation
-0.011
CY2020 cydy Effective Income Tax Rate Reconciliation Non Deductible Expense Irc162 Limitation
EffectiveIncomeTaxRateReconciliationNonDeductibleExpenseIrc162Limitation
-0.024
CY2019 cydy Effective Income Tax Rate Reconciliation Non Deductible Expense Irc162 Limitation
EffectiveIncomeTaxRateReconciliationNonDeductibleExpenseIrc162Limitation
0
CY2021 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense Share Based Compensation Cost
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost
0.017
CY2020 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense Share Based Compensation Cost
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost
0.032
CY2019 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense Share Based Compensation Cost
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost
0
CY2021 cydy Effective Income Tax Rate Reconciliation Nondeductible Legal Settlement Expense
EffectiveIncomeTaxRateReconciliationNondeductibleLegalSettlementExpense
-0.012
CY2020 cydy Effective Income Tax Rate Reconciliation Nondeductible Legal Settlement Expense
EffectiveIncomeTaxRateReconciliationNondeductibleLegalSettlementExpense
-0.038
CY2019 cydy Effective Income Tax Rate Reconciliation Nondeductible Legal Settlement Expense
EffectiveIncomeTaxRateReconciliationNondeductibleLegalSettlementExpense
0
CY2021 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
-0.150
CY2020 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
-0.131
CY2019 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
-0.169
CY2021 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.000
CY2020 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.000
CY2019 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.048
CY2021Q2 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
74258000
CY2020Q2 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
55624000
CY2021Q2 us-gaap Deferred Tax Assets Tax Credit Carryforwards
DeferredTaxAssetsTaxCreditCarryforwards
2063000
CY2020Q2 us-gaap Deferred Tax Assets Tax Credit Carryforwards
DeferredTaxAssetsTaxCreditCarryforwards
2063000
CY2021Q2 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits
5510000
CY2020Q2 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits
4069000
CY2021Q2 cydy Charitable Contribution Carry Forward
CharitableContributionCarryForward
14000
CY2020Q2 cydy Charitable Contribution Carry Forward
CharitableContributionCarryForward
0
CY2021Q2 cydy Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Vacation And Payroll Expenses
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedVacationAndPayrollExpenses
87000
CY2020Q2 cydy Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Vacation And Payroll Expenses
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedVacationAndPayrollExpenses
112000
CY2021Q2 us-gaap Deferred Tax Liabilities Leasing Arrangements
DeferredTaxLiabilitiesLeasingArrangements
3000
CY2020Q2 us-gaap Deferred Tax Liabilities Leasing Arrangements
DeferredTaxLiabilitiesLeasingArrangements
0
CY2021Q2 us-gaap Deferred Tax Assets Inventory
DeferredTaxAssetsInventory
146000
CY2021Q2 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities
874000
CY2020Q2 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities
349000
CY2021Q2 us-gaap Deferred Tax Liabilities Property Plant And Equipment
DeferredTaxLiabilitiesPropertyPlantAndEquipment
0
CY2020Q2 us-gaap Deferred Tax Liabilities Property Plant And Equipment
DeferredTaxLiabilitiesPropertyPlantAndEquipment
1000
CY2021Q2 cydy Deferred Tax Assets Amortization
DeferredTaxAssetsAmortization
396000
CY2020Q2 cydy Deferred Tax Assets Amortization
DeferredTaxAssetsAmortization
373000
CY2021Q2 us-gaap Deferred Tax Liabilities Financing Arrangements
DeferredTaxLiabilitiesFinancingArrangements
0
CY2020Q2 us-gaap Deferred Tax Liabilities Financing Arrangements
DeferredTaxLiabilitiesFinancingArrangements
0
CY2021Q2 cydy Deferred Tax Assets Liability Difference In Acquired Assets
DeferredTaxAssetsLiabilityDifferenceInAcquiredAssets
91000
CY2020Q2 cydy Deferred Tax Assets Liability Difference In Acquired Assets
DeferredTaxAssetsLiabilityDifferenceInAcquiredAssets
2483000
CY2021Q2 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
83254000
CY2020Q2 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
60106000
CY2021Q2 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
0
CY2020Q2 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
0
CY2021Q2 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
83254000
CY2020Q2 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
60106000
CY2021Q2 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
83254000
CY2020Q2 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
60106000
CY2021Q2 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
0
CY2020Q2 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
0
CY2021Q2 us-gaap Deferred Tax Assets Operating Loss Carryforwards Subject To Expiration
DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration
353600000
CY2020Q2 us-gaap Deferred Tax Assets Operating Loss Carryforwards Subject To Expiration
DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration
264900000
CY2019Q2 us-gaap Deferred Tax Assets Operating Loss Carryforwards Subject To Expiration
DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration
190500000
CY2019Q2 cydy Percentage Of Shares Issuable Upon Exercise Of Original Warrants
PercentageOfSharesIssuableUponExerciseOfOriginalWarrants
0.50

Files In Submission

Name View Source Status
0001558370-21-009730-index-headers.html Edgar Link pending
0001558370-21-009730-index.html Edgar Link pending
0001558370-21-009730.txt Edgar Link pending
0001558370-21-009730-xbrl.zip Edgar Link pending
cydy-20210531.xsd Edgar Link pending
cydy-20210531x10k.htm Edgar Link pending
cydy-20210531x10k004.jpg Edgar Link pending
cydy-20210531x10k_htm.xml Edgar Link completed
cydy-20210531xex10d10.htm Edgar Link pending
cydy-20210531xex10d68.htm Edgar Link pending
cydy-20210531xex10d7.htm Edgar Link pending
cydy-20210531xex10d8.htm Edgar Link pending
cydy-20210531xex10d9.htm Edgar Link pending
cydy-20210531xex21.htm Edgar Link pending
cydy-20210531xex23.htm Edgar Link pending
cydy-20210531xex24.htm Edgar Link pending
cydy-20210531xex31d1.htm Edgar Link pending
cydy-20210531xex31d2.htm Edgar Link pending
cydy-20210531xex32.htm Edgar Link pending
cydy-20210531xex4d1.htm Edgar Link pending
cydy-20210531_cal.xml Edgar Link unprocessable
cydy-20210531_def.xml Edgar Link unprocessable
cydy-20210531_lab.xml Edgar Link unprocessable
cydy-20210531_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R72.htm Edgar Link pending
R73.htm Edgar Link pending
R74.htm Edgar Link pending
R75.htm Edgar Link pending
R76.htm Edgar Link pending
R77.htm Edgar Link pending
R78.htm Edgar Link pending
R79.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending